:: Library Catalog

Imatge de la portada

Guardat en:

Dades bibliogràfiques
Autor principal:	Liangwei Yin (尹良威)
Format:	Recurso digital
Idioma:
Publicat:	Zenodo 2025
Accés en línia:	https://doi.org/10.5281/zenodo.15697455
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars

Comprehensive analysis of pain genes in prognosis of kidney renal clear cell carcinoma and tumor immunotherapy: A comprehensive bioinformatic study
per: Xiao‐Yu Zhuang, et al.
Publicat: (2024)

Acanthosis Nigricans associated with clear-cell renal cell carcinoma
per: Fernando Peixoto Ferraz de Campos
Publicat: (2016)

Exosome‐related lncRNA score: A value‐based individual treatment strategy for predicting the response to immunotherapy in clear cell renal cell carcinoma
per: Zhan Yang, et al.
Publicat: (2024)

Unveiling the impact of tertiary lymphoid structures on immunotherapeutic responses of clear cell renal cell carcinoma
per: Wenhao Xu, et al.
Publicat: (2024)

Durable response to nivolumab rechallenge in a patient with metastatic clear cell renal cell carcinoma
per: Motohiro Fujiwara, et al.
Publicat: (2024)

Synchronous clear cell renal cell carcinoma and classic Hodgkin lymphoma
per: Phuoc Christie‐Nguyen, et al.
Publicat: (2025)

Belzutifan's role in the treatment landscape of clear cell renal cell carcinoma
per: Adrienne H. Chen, et al.
Publicat: (2025)

Identification of metabolic dysregulation and biomarkers for clear cell renal cell carcinoma
per: Bin Zheng, et al.
Publicat: (2024)

Differences in mutations across tumour sizes in clear‐cell renal cell carcinoma
per: Steven M. Monda, et al.
Publicat: (2024)

A multimodal deep learning framework for predicting sunitinib response in advanced clear cell renal cell carcinoma
per: Xi Tian, et al.
Publicat: (2025)

Diagnostic, predictive and prognostic molecular biomarkers in clear cell renal cell carcinoma: A retrospective study
per: Jian Deng, et al.
Publicat: (2024)

Multi‐instance learning for identifying high‐risk subregions associated with synchronous distant metastasis in clear cell renal cell carcinoma
per: Ling‐Feng Xue, et al.
Publicat: (2024)

Single‐cell transcriptomic analysis in clear cell renal cell carcinoma: Deciphering the role of APP within the tumour microenvironment
per: Bo Guan, et al.
Publicat: (2024)

Immunogenic cell death–related genes predict prognosis and response to immunotherapy in lung squamous cell carcinoma
per: Guoping Li, et al.
Publicat: (2024)

Role of tertiary lymphoid structures in the tumour microenvironment and immunotherapy response of renal cell carcinoma
per: Lin Yang, et al.
Publicat: (2025)

Unravelling infiltrating T‐cell heterogeneity in kidney renal clear cell carcinoma: Integrative single‐cell and spatial transcriptomic profiling
per: Haiqing Chen, et al.
Publicat: (2024)

Identifying genes associated with disease outcomes using joint sparse canonical correlation analysis—An application in renal clear cell carcinoma
per: Diptavo Dutta, et al.
Publicat: (2024)

Comprehensive analyses of nuclear mitochondria‐related genes in the molecular features, immune infiltration, and drug sensitivity of clear cell renal cell carcinoma
per: Yuchen Zhang, et al.
Publicat: (2024)

A multimodal ensemble approach for clear cell renal cell carcinoma treatment outcome prediction
per: Chen, Meixu, et al.
Publicat: (2024)

MFN2 suppresses the accumulation of lipid droplets and the progression of clear cell renal cell carcinoma
per: Zhiduan Cai, et al.
Publicat: (2024)

CPA4 as a biomarker promotes the proliferation, migration and metastasis of clear cell renal cell carcinoma cells
per: Kongjia Wang, et al.
Publicat: (2024)

First‐line immunotherapy of metastatic renal cell carcinoma: an updated network meta‐analysis including triplet therapy
per: Takafumi Yanagisawa, et al.
Publicat: (2024)

Proteomic profiling of ovarian clear cell carcinomas identifies prognostic biomarkers for chemotherapy
per: Liang Yue, et al.
Publicat: (2024)

A single gene mutation predicts response to immune checkpoint blockade in ovarian clear cell carcinoma
per: Matheus Henrique Dias, et al.
Publicat: (2025)

Nc‐RNA‐mediated low expression of AZIN1 correlated with unfavorable prognosis in kidney renal clear cell carcinoma
per: Xinyi Zeng, et al.
Publicat: (2024)

CRYAB is upregulated and predicts clinical prognosis in kidney renal clear cell carcinoma
per: Hao Ren, et al.
Publicat: (2025)

Integrative analysis of bulk and single‐cell RNA sequencing reveals sphingolipid metabolism and immune landscape in clear cell renal cell carcinoma
per: Dongdong Xie, et al.
Publicat: (2024)

Paraoxonase‐2 shRNA‐mediated gene silencing suppresses proliferation and migration, while promotes chemosensitivity in clear cell renal cell carcinoma cell lines
per: Valentina Schiavoni, et al.
Publicat: (2024)

Adjuvant immunotherapy for high‐risk renal cell carcinoma—now or never?
per: Tivya Kulasegaran, et al.
Publicat: (2024)

CLEC18A interacts with sulfated glycosaminoglycans and controls clear cell renal cell carcinoma progression
per: Gustav Jonsson, et al.
Publicat: (2025)

Metastatic risk in clear cell renal cell carcinoma: a tool incorporating sex, size, and grade
per: Frederik F. Thomsen, et al.
Publicat: (2024)

Volumetric imaging of the tumor microvasculature reflects outcomes and genomic states of clear cell renal cell carcinoma
per: Yuta Kaneko, et al.
Publicat: (2024)

Macrophage migration inhibitory factor (MIF) predicts survival in patients with clear cell renal cell carcinoma
per: Martyna Parol‐Kulczyk, et al.
Publicat: (2024)

Comprehensive analysis of m6A methylome and transcriptome by Nanopore sequencing in clear cell renal carcinoma
per: Hexin Li, et al.
Publicat: (2024)

CD2AP is a potential prognostic biomarker of renal clear cell carcinoma
per: Can Chen, et al.
Publicat: (2024)

A case of complete response to avelumab plus axitinib combination therapy for metastatic clear cell renal cell carcinoma in a kidney undergoing dialysis
per: Ei Shiomi, et al.
Publicat: (2024)

Tumor‐associated macrophages impair NK cell IFN‐γ production and contribute to tumor progression in clear cell renal cell carcinoma
per: Sol Yanel Núñez, et al.
Publicat: (2024)

Carbonic anhydrase‐9‐targeted near‐infrared photoimmunotherapy as a theranostic modality for clear cell renal cell carcinoma
per: Hiroshi Fukushima, et al.
Publicat: (2025)

Diagnostic value of imaging in patients with clear cell papillary renal cell carcinoma: A case series and literature review
per: Yuxuan Song, et al.
Publicat: (2024)

Papillary renal cell carcinoma with high‐ ABCC2 shows an immune‐evasive profile associated with favorable response to immunotherapy
per: Vincent Francis Castillo, et al.
Publicat: (2025)